Table 1.
Comparison of Baseline and Follow Up Measures
| Characteristic or Measurement |
Baseline | Follow up | Change from Baseline to Follow up (P value)b |
|---|---|---|---|
| BMI, kg/m2 | 36.1(6.03) | 36.4 (6.11) | .32 |
| IPAQ score | 1786.6(1506.2) | 2799.1 (3834.6) | .21 |
| SCQ score, mg/day* | 1102.7(304.3) | 975.5 (282.2) | .02 |
| 25(OH)D, nmol/L | 55.9(12.2) | 86.9±16.7 | <.001 |
| Serum PTH, pmol/L | 4.1 (1.6) | 3.3(1.1) | .0123 |
| Fasting glucose, mmol/L | 4.9(0.28) | 4.97(0.26) | .09 |
| Fasting insulin pmol/L | 225.71(127.93) | 245.16(150.01) | .27 |
| HOMA-IR | 7.11(4.18) | 7.9(5.10) | .18 |
| hs-CRP, nmol/L | 47.62(35.43) | 40(25.7) | .33 |
| LDL cholesterol, mmol/L | 1.95(0.66) | 2.15(0.81) | .05 |
| HDL cholesterol, mmol/L | 1.2(0.28) | 1.16(0.23) | .41 |
| Total cholesterol, mmol/L | 3.69(0.71) | 4.03(0.87) | <.01 |
| Triglycerides, mmol/L | 1.19(0.57) | 1.58(0.81) | <.01 |
| Urine calcium to creatinine | 67.8(59.2) | 87.7(73.2) | .32 |
| Mean FMD (%)c | 9.5(3.52) | 10.4(3.82) | .59 |
| Mean RHI (%)c | 449.3(243.5) | 513.9(325.6) | .47 |
Abbreviations: 25(OH)D, 25-hydroxy vitamin D; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); hs-CRP, high-sensitivity C-reactive protein; FMD, flow-mediated dilatation; HDL, high-density lipoprotein; HOMA-IR, Homeostatic Model Assessment-Insulin Resistance; IPAQ, international physical activity questionnaire; LDL, low-density lipoprotein; RHI, reactive hyperemia index; SCQ, short calcium questionnaire; PTH, parathyroid hormone
a
Values are presented as mean (SD) unless otherwise indicated.
b
Wilcoxon Signed rank test
c
n=18
P value represents significant change from baseline to follow up